What’s So Special About Specialty Drugs? Although there is no industry standard definition for specialty drugs, they are typically extremely high-cost prescription drugs, primarily used to treat complicated and chronic conditions. The drugs included on a specialty drug list may vary between vendors, however there are several features that are common among specialty drugs: Extremely
With the opioid epidemic receiving national attention in recent years, members of National CooperativeRx are asking what is being done to combat the issue. One of our in-house pharmacists, Jocelyn Kerl, takes a closer look. Nationally Legislation has influenced the expansion of prescription drug monitoring programs (PDMPs) nationwide. PDMPs help support access to controlled substances
My name is Emily Torgerson and I am pleased to announce my new position as a Communications Specialist with National CooperativeRx. Hailing from Eau Claire, WI with a strong background in public relations and communications, I am excited to begin this new journey here in Madison.
National Cooperative Rx’s Annual Report has been completed and our financial information from 2016 is available to the public. For a comprehensive overview, please check out our 2017 Annual Report. 2016 was a groundbreaking year for National CooperativeRx and our members. With 78,314 participants joining us from 34 new member groups across the country, we have participants in every state!
Paul Meyer, Board Chair, kicked off the National CooperativeRx Annual Meeting yesterday by welcoming the audience and introducing our board members. Josh Bindl gave a presentation highlighting National CooperativeRx’s achievements in 2016, acknowledging current PBM industry issues, and providing the Cooperative’s strategies on balancing out a high level of pharmaceutical care with rising costs. Highlights from
Most people envision a pharmacist wearing a white lab coat refilling prescriptions at the local pharmacy. Jocelyn Kerl, the newest clinical services manager at National CooperativeRx, proves that’s not always the case. Her role within our organization consists of account management and plan design, while keeping our members’ best interests at heart. Along with our
Never in the history of the Cooperative have we added as many participants as in 2016. It was a record year with 78,314 new participants joining us from 34 new member groups. Totaling over a quarter million participants, National CooperativeRx has never been this large or had this much purchasing strength.
As I begin as CEO of National CooperativeRx, my focus will be on the members. While directing the benefit plans for WCA Group Health Trust gives me a good base, my experience is by no means all encompassing. I look forward to speaking with each of you to gain knowledge and perspective. Together we can achieve new heights.